| 1 |
van Diepen S, Katz JN, Albert NM, et al. Contemporary management of cardiogenic shock: a scientific statement from the american heart association[J]. Circulation, 2017, 136(16): e232-e268.
|
| 2 |
Mebazaa A, Combes A, van Diepen S, et al. Management of cardiogenic shock complicating myocardial infarction[J]. Intensive Care Med, 2018, 44(6): 760-773.
|
| 3 |
Vincent JL, De Backer D. Circulatory shock[J]. N Engl J Med, 2013, 369(18): 1726-1734.
|
| 4 |
Thiele H, Ohman EM, de Waha-Thiele S, et al. Management of cardiogenic shock complicating myocardial infarction: an update 2019[J]. Eur Heart J, 2019, 40(32): 2671-2683.
|
| 5 |
Bellumkonda L, Gul B, Masri SC. Evolving concepts in diagnosis and management of cardiogenic shock[J]. Am J Cardiol, 2018, 122(6): 1104-1110.
|
| 6 |
Hajjar LA, Teboul JL. Mechanical circulatory support devices for cardiogenic shock: state of the art[J]. Critical Care, 2019, 23(1): 76.
|
| 7 |
Taleb I, Koliopoulou AG, Tandar A, et al. Shock team approach in refractory cardiogenic shock requiring short-term mechanical circulatory support: a proof of concept[J]. Circulation, 2019, 140(1): 98-100.
|
| 8 |
Combes A, Brodie D, Chen YS, et al. The ICM research agenda on extracorporeal life support[J]. Intensive Care Med, 2017, 43(9): 1306-1318.
|
| 9 |
Kapelios CJ, Terrovitis JV, Nanas JN. Current and future applications of the intra-aortic balloon pump[J]. Curr Opin Cardiol, 2014, 29(3): 258-265.
|
| 10 |
Prondzinsky R, Unverzagt S, Russ M, et al. Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial[J]. Shock, 2012, 37(4): 378-384.
|
| 11 |
Thiele H, Zeymer U, Neumann FJ, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock[J]. N Engl J Med, 2012, 367(14): 1287-1296.
|
| 12 |
Thiele H, Zeymer U, Neumann FJ, et al. Intra-aortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial[J]. Lancet, 2013, 382(9905): 1638-1645.
|
| 13 |
Thiele H, Zeymer U, Thelemann N, et al. Intraaortic balloon pump in cardiogenic shock complicating acute myocardial infarction: long-term 6-year outcome of the randomized IABP-SHOCK II trial[J]. Circulation, 2019, 139: 395-403.
|
| 14 |
Sandhu A, McCoy LA, Negi SI, et al. Use of mechanical circulatory support in patients undergoing percutaneous coronary intervention: insights from the National Cardiovascular Data Registry[J]. Circulation, 2015, 132(13): 1243-1251.
|
| 15 |
Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization[J]. Eur Heart J, 2019, 40(2): 87-165.
|
| 16 |
Miceli A, Fiorani B, Danesi TH, , et al. Prophylactic intra-aortic balloon pump in high-risk patients undergoing coronary artery bypass grafting: a propensity score analysis[J]. Interact Cardiovasc Thorac Surg, 2009, 9(2): 291-294.
|
| 17 |
Keebler ME, Haddad EV, Choi CW, et al. Venoarterial extracorporeal membrane oxygenation in cardiogenic shock[J]. JACC Heart Fail, 2018, 6(6): 503-516.
|
| 18 |
Rao P, Khalpey Z, Smith R, et al. Venoarterial extracorporeal membrane oxygenation for cardiogenic shock and cardiac arrest[J]. Circ Heart Fail, 2018, 11(9): e004905.
|
| 19 |
Guglin M, Zucker MJ, Bazan VM, et al. Venoarterial ECMO for Adults: JACC Scientific Expert Panel[J]. J Am Coll Cardiol, 2019, 73(6): 698-716.
|
| 20 |
Ouweneel DM, Schotborgh JV, Limpens J, et al. Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis[J]. Intensive Care Med, 2016, 42(12): 1922-1934.
|
| 21 |
Eckman PM, Katz JN, El Banayosy A, et al. Veno-arterial extracorporeal membrane oxygenation for cardiogenic shock: an introduction for the busy clinician[J]. Circulation, 2019, 140(24): 2019-2037.
|
| 22 |
Bougouin W, Dumas F, Lamhaut L, et al. Extracorporeal cardiopulmonary resuscitation in out-of-hospital cardiac arrest: a registry study[J]. Eur Heart J, 2019 Oct 31. pii: ehz753
|
| 23 |
Ostadal P, Rokyta R, Kruger A, et al. Extra corporeal membrane oxygenation in the therapy of cardiogenic shock (ECMO-CS): rationale and design of the multicenter randomized trial[J]. Eur J Heart Fail, 2017, 19 (Suppl 2): 124-127.
|
| 24 |
Chang CH, Chen HC, Caffrey JL, et al. Survival analysis after extracorporeal membrane oxygenation in critically III adults: a nationwide cohort study[J]. Circulation, 2016, 133(24): 2423-2433.
|
| 25 |
Vallabhajosyula S, Prasad A, Bell MR, et al. Extracorporeal membrane oxygenation use in acute myocardial infarction in the United States, 2000 to 2014[J]. Circ Heart Fail, 2019, 12(12): e005929.
|
| 26 |
Han JJ, Swain JD. The perfect ECMO candidate[J]. J Am Coll Cardiol, 2018, 71(10): 1178-1182.
|
| 27 |
Lopez-Sobrino T, Yusef H, Gershlick T. Predicting outcomes in cardiogenic shock: are we at risk of having too many scores but too little information?[J]. Eur Heart J, 2019, 40(32): 2695-2699.
|
| 28 |
Cheng R, Hachamovitch R, Kittleson M, et al. Complications of extracorporeal membrane oxygenation for treatment of cardiogenic shock and cardiac arrest: a meta-analysis of 1,866 adult patients[J]. Ann Thorac Surg, 2014, 97(2): 610-616.
|
| 29 |
Bonicolini E, Martucci G, Simons J, et al. Limb ischemia in peripheral veno-arterial extracorporeal membrane oxygenation: a narrative review of incidence, prevention, monitoring, and treatment[J]. Crit Care, 2019, 23(1): 266.
|
| 30 |
Thiele H, Sick P, Boudriot E, et al. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock[J]. Eur Heart J., 2005, 26(13): 1276-1283.
|
| 31 |
Seyfarth M, Sibbing D, Bauer I, , et al. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction[J]. J Am Coll Cardiol, 2008, 52(19): 1584-1588.
|
| 32 |
Kar B, Gregoric ID, Basra SS, , et al. The percutaneous ventricular assist device in severe refractory cardiogenic shock[J]. J Am Coll Cardiol, 2011, 57(6): 688-696.
|
| 33 |
Lauten A, Engstrom AE, Jung C, et al. Percutaneous left-ventricular support with the Impella-2.5-assist device in acute cardiogenic shock: results of the Impella-EUROSHOCK-registry[J]. Circ Heart Fail, 2013, 6(1): 23-30.
|
| 34 |
Ouweneel DM, Eriksen E, Sjauw KD, et al. Percutaneous mechanical circulatory support versus intra-aortic balloon pump in cardiogenic shock after acute myocardial infarction[J]. J Am Coll Cardiol, 2017, 69(3): 278-287.
|
| 35 |
Thiele H, Jobs A, Ouweneel DM, et al. Percutaneous short-term active mechanical support devices in cardiogenic shock: a systematic review and collaborative meta-analysis of randomized trials[J]. Eur Heart J, 2017, 38(47): 3523-3531.
|
| 36 |
Schrage B, Ibrahim K, Loehn T, et al. Impella support for acute myocardial infarction complicated by cardiogenic shock[J]. Circulation, 2019, 139(10): 1249-1258.
|
| 37 |
Poulidakis E, Spaulding C. Cardiac assist devices in cardiogenic shock[J]. Circulation, 2019, 139(10): 1259-1261.
|
| 38 |
O′Neill WW, Grines C, Schreiber T, et al. Analysis of outcomes for 15,259 US patients with acute myocardial infarction cardiogenic shock (AMICS) supported with the Impella device[J]. Am Heart J, 2018, 202: 33-38.
|
| 39 |
Amin AP, Spertus JA, Curtis JP, et al. The evolving landscape of impella(r) use in the united states among patients undergoing percutaneous coronary intervention with mechanical circulatory support[J]. Circulation, 2020, 141(4): 273-284.
|
| 40 |
Kapur NK, Esposito ML, Bader Y, et al. Mechanical circulatory support devices for acute right ventricular failure[J]. Circulation, 2017, 136(3): 314-326.
|
| 41 |
Anderson MB, Goldstein J, Milano C, et al. Benefits of a novel percutaneous ventricular assist device for right heart failure: The prospective RECOVER RIGHT study of the Impella RP device[J]. J Heart Lung Transplant, 2015, 34(12): 1549-1560.
|